Researchers will explore the use of tiny particles called extracellular vesicles to deliver chemotherapy drugs directly to hemangiosarcoma cancer cells to pave the way for the development of much-needed new treatments.
Researchers will use a novel approach to differentiate between cancerous and normal cells surrounding splenic hemangiosarcoma tumors to improve successful tumor removal and drug delivery.
Researchers will search for new therapy targets for hemangiosarcoma in dogs to inform the development of much-needed therapies and preventives for this deadly cancer.
Researchers are creating tools to estimate fracture risk in giant-breed dogs with osteosarcoma as well as evaluating a novel method to stabilize the affected bone.